M. Lebmeier
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Pharmaceutical Economics and Policy 1
-
- Rheumatoid Arthritis Research and Therapies 2
- Oropharyngeal Anatomy and Pathologies 1
- Co-authors
- Mark J. C. Nuijten (4 shared papers)Dyfrig Arwyn Hughes (1 shared paper)Maribel Salas (1 shared paper)L. Pericleous (3 shared papers)Dawn Lee (3 shared papers)Anthony James Hatswell (2 shared papers)Patricia Guyot (2 shared papers)Peter Charles Taylor (2 shared papers)
- Journals
- Value in Health (4 papers)Lara D. Veeken (3 papers)Journal of Medical Economics (2 papers)Mycoses (1 paper)The Journal of Rheumatology (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
M. Lebmeier
15 papers receiving 408 citations
Peers
Comparison fields: 5 of 51
- Family Practice 63
- Rheumatology 83
- Epidemiology 151
- Economics and Econometrics 133
- Endocrinology, Diabetes and Metabolism 28
Countries citing papers authored by M. Lebmeier
This map shows the geographic impact of M. Lebmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lebmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lebmeier more than expected).
Fields of papers citing papers by M. Lebmeier
This network shows the impact of papers produced by M. Lebmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lebmeier. The network helps show where M. Lebmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lebmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 101 | |
| 2 | 2007 | 83 | |
| 3 | 2011 | 42 | |
| 4 | 2014 | 41 | |
| 5 | 2010 | 37 | |
| 6 | 2008 | 33 | |
| 7 | 2009 | 22 | |
| 8 | 2009 | 19 | |
| 9 | 2012 | 19 | |
| 10 | 2015 | 17 | |
| 11 | 2020 | 12 | |
| 12 | 2013 | 5 | |
| 13 | 2012 | 3 | |
| 14 | 2005 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2006 | 0 | |
| 17 | 2026 | 0 |
About M. Lebmeier
M. Lebmeier is a scholar working on Economics and Econometrics, Rheumatology, Epidemiology, Family Practice and Pathology and Forensic Medicine, having authored 17 papers that have together received 436 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Respiratory viral infections research (6 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Antifungal resistance and susceptibility (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Oropharyngeal Anatomy and Pathologies (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Family Practice (63 citations), Rheumatology (83 citations), Epidemiology (151 citations), Economics and Econometrics (133 citations) and Endocrinology, Diabetes and Metabolism (28 citations). M. Lebmeier has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Mark J. C. Nuijten, Dyfrig Arwyn Hughes, Maribel Salas, L. Pericleous, Dawn Lee, Anthony James Hatswell, Patricia Guyot, Peter Charles Taylor, Gert Bergman and Robin Christensen. Their work appears in journals such as Value in Health, Lara D. Veeken, Journal of Medical Economics, Mycoses and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.